🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchOrforglipron ATTAIN-4 — looking for input Page 3

Orforglipron ATTAIN-4 — looking for input

LabKate Sat, Feb 7, 2026 at 2:59 PM 14 replies 1,111 viewsPage 3 of 3
zoe_NC
Member
278
1,234
Nov 2024
Charlotte, NC
Feb 7, 2026 at 7:14 PM#11
BethLabQueen said:
Orforglipron ATTAIN-4 looking for is not that straightforward in my experience

This is exactly right. BethLabQueen articulated what I have been trying to explain to my friends for months. The Orforglipron ATTAIN-4 aspect is what made the difference for me.

39 5Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 36 others
Reply Quote Save Share Report
emma_london
Member
312
1,456
Oct 2024
London, UK
Feb 7, 2026 at 7:31 PM#12

Reading this thread on Orforglipron ATTAIN-4 hits close to home. Dad of 2 checking in — I started at 293 lbs and felt like I would tried everything.

9 months on tirz and I am a different person. Not just the 68 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Orforglipron — take the leap. It was the best health decision I have ever made. ❤️

Last edited: Feb 8, 2026 at 1:31 AM
45 7mike.trainer_LA, sarah_nash92, FitDadDave and 42 others
Reply Quote Save Share Report
JenMemphis
Member
267
1,234
Jan 2025
Memphis, TN
Feb 7, 2026 at 7:48 PM#13

rachel_ABQ — that is really helpful context on Orforglipron ATTAIN-4 . Follow-up question: how long did you wait before increasing your dose?

I am in a similar situation (week 4) and trying to set realistic expectations.

Last edited: Feb 8, 2026 at 12:48 AM
47 24NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 44 others
Reply Quote Save Share Report
anders_CPH
Senior Member
1,567
7,234
Feb 2024
Copenhagen, DK
Feb 7, 2026 at 8:05 PM#14

To answer emma_london's question specifically:

From a clinical standpoint, Orforglipron ATTAIN-4 looking is a reasonable concern that deserves a thorough answer.

The short answer: the evidence supports this approach for most patients.

The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.

50 19BethLabQueen, ChrisMacros, KetoKyle and 47 others
Reply Quote Save Share Report
sarah_TO
Member
278
1,234
Sep 2024
Toronto, CA
Feb 7, 2026 at 8:22 PM#15

Bookmarked 📌 The Orforglipron info in this thread is essential. Coming back to this for sure.

24 11DanielChem_CHI, marco_milano, pam_columbus and 21 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register